ME-Derived eα52-68 peptide presented by 112Ab interferes with clonal deletion of autoreactive T cells in autoimmune thyroiditis

被引:5
作者
Brown, Nicholas K. [1 ]
McCormick, Daniel J. [2 ]
David, Chella S. [3 ]
Kong, Yi-chi M. [1 ]
机构
[1] Wayne State Univ, Sch Med, Dept Immunol & Microbiol, Detroit, MI 48201 USA
[2] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[3] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA
关键词
D O I
10.4049/jimmunol.180.10.7039
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Susceptibility and resistance to experimental autoimmune thyroiditis is encoded by MHC H2A genes. We reported that traditionally resistant B10 (H2(b)) mice permit thyroiditis induction with mouse thyroglobulin (mTg) after depleting regulatory T cells (Tregs), supportin A(b) presentation to thyroiditogenic T cells. Yet, Ea(k) transgenic mice, expressing Ab and normally absent E-b molecules (E(+)B10 mice), are susceptible to thyroiditis induction without Treg depletion. To explore the effect of E-b expression on mTg presentation by A(b), seven putative A(b)-binding, 15-16-mer peptides were synthesized. Five were immunogenic for both B10 and E(+)B10 mice. The effect of E-b expression was tested by competition with an E alpha 52-68 peptide, because E alpha 52-68 occupies similar to 15% of A(b) Molecules in E(+)B10 mice, binding with high affinity. E alpha 52-68 competitively reduced the proliferative response to mTg, mTg1677, and mTg2342 of lymph node cells primed to each Ag. Moreover, mTg1677 induced mild thyroiditis in Treg-depleted B10 mice, and in E(+)B10 mice without the need for Treg depletion. Ea52-68 competition with mTg-derived peptides may impede clonal deletion of pathogenic, mTg-specific T cells in the thymus.
引用
收藏
页码:7039 / 7046
页数:8
相关论文
共 42 条
[1]
H2-O influence on antigen presentation in H2-E-expressing mice [J].
Alfonso, C ;
Williams, GS ;
Karlsson, L .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (07) :2014-2021
[2]
REGULATION OF EXPERIMENTAL AUTOIMMUNE-THYROIDITIS - MAPPING OF SUSCEPTIBILITY TO THE I-A SUBREGION OF THE MOUSE H-2 [J].
BEISEL, KW ;
DAVID, CS ;
GIRALDO, AA ;
KONG, YM ;
ROSE, NR .
IMMUNOGENETICS, 1982, 15 (04) :427-430
[3]
IMMUNOGENICITY AND TOLEROGENICITY OF SELF-MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDES [J].
BENICHOU, G ;
TAKIZAWA, PA ;
HO, PT ;
KILLION, CC ;
OLSON, CA ;
MCMILLAN, M ;
SERCARZ, EE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (05) :1341-1346
[4]
A human class II MHC-derived peptide antagonizes phosphatidylinositol 3-kinase to block IL-2 signaling [J].
Boytim, ML ;
Lilly, P ;
Drouvalakis, K ;
Lyu, SC ;
Jung, R ;
Krensky, AM ;
Clayberger, C .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (10) :1447-1453
[5]
BRAUNSTEIN NS, 1990, J IMMUNOL, V145, P1635
[6]
Carayanniotis G, 2000, Int Rev Immunol, V19, P557
[7]
Cloning and characterization of murine thyroglobulin cDNA [J].
Caturegli, P ;
Vidalain, PO ;
Vali, M ;
AguileraGalaviz, LA ;
Rose, NR .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 85 (02) :221-226
[8]
A self MHC class II β-chain peptide prevents diabetes in nonobese diabetic mice [J].
Chaturvedi, P ;
Agrawal, B ;
Zechel, M ;
Lee-Chan, E ;
Singh, B .
JOURNAL OF IMMUNOLOGY, 2000, 164 (12) :6610-6620
[9]
CHRISTADOSS P, 1990, IMMUNOGENETICS, V31, P241
[10]
MICE LACKING MHC CLASS-II MOLECULES [J].
COSGROVE, D ;
GRAY, D ;
DIERICH, A ;
KAUFMAN, J ;
LEMEUR, M ;
BENOIST, C ;
MATHIS, D .
CELL, 1991, 66 (05) :1051-1066